Indian Pharma October 2025 Sales Data

1. Overall Market Growth & Trends (IPM Key Highlights):

• Robust Monthly Growth: The IPM experienced a significant surge in monthly growth for October 2025, reaching 11.7%, a substantial increase from 6.1% in September 2025.
• Healthy MAT Growth: Correspondingly, the Moving Annual Total (MAT) growth for October 2025 also improved to 8.4% compared to 7.8% in September 2025.
• Strong Long-Term Growth: The IPM has demonstrated a healthy Compound Annual Growth Rate (CAGR) of almost 10% over the observed period (MAT Oct'20 to MAT Oct'25), indicating sustained expansion.
• October Sales Dynamics: While October sales are typically lower than September, October 2025 showed a higher sale, particularly driven by the chronic segment, due to lower growth reported in the preceding month.